For instance, in mutant melanoma with BRAF inhibitor treatment, Grp78 binds the scaffold protein KSR2 to form a multiprotein complex, which acts independently of the UPR to activate ERK and promote the phosphorylation of ATF4 [41]. This evidence concerns the gene KSR2 and melanoma.